# Endoscopic Sleeve Gastroplasty Plus Duodenal pulsENDO for Obese T2DM

> **NCT07660445** · NA · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 20 (estimated)

## Conditions studied

- Obesity Type 2 Diabetes Mellitus

## Interventions

- **PROCEDURE:** Endoscopic sleeve gastroplasty plus duodenal recellularization via electroporation therapy (pulsENDO)

## Key facts

- **NCT ID:** NCT07660445
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2029-07-31
- **Final completion:** 2031-07-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660445, "Endoscopic Sleeve Gastroplasty Plus Duodenal pulsENDO for Obese T2DM". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*